What's Happening?
On May 26, 2026, the Superior Court of New Jersey, Appellate Division, ruled that individuals denied employment due to positive cannabis tests can sue their employers under the New Jersey Cannabis Regulatory, Enforcement Assistance, and Market Modernization
Act (CREAMMA). This decision came from the case Sanders v. The Levari Group, LLC, where Darlene Sanders was denied a job after testing positive for cannabis metabolites. The court found that CREAMMA provides an implied private right of action, allowing individuals to seek legal recourse if they face employment discrimination based on cannabis use. This ruling reverses a previous trial court decision that dismissed Sanders' claim, stating that her remedy was through the Cannabis Regulatory Commission.
Why It's Important?
This ruling is significant as it sets a precedent for employment rights related to cannabis use in New Jersey. Employers must now reconsider their drug testing policies to comply with CREAMMA's anti-discrimination provisions. The decision could influence similar cases in other states where recreational cannabis is legal, potentially leading to broader changes in employment practices across the U.S. Employers may face increased litigation risks if they do not adapt their policies to align with this new legal interpretation, impacting hiring practices and workplace regulations.
What's Next?
New Jersey employers are advised to review and possibly revise their pre-employment drug testing and hiring procedures to ensure compliance with CREAMMA. This decision may prompt other states to evaluate their cannabis-related employment laws, potentially leading to similar legal challenges and rulings. Employers nationwide should monitor developments in this area to mitigate legal risks and ensure fair employment practices.
